Elevated circulating phospholipid transporter protein activity is associated with 28-day mortality in patients with sepsis

Objectives Phospholipid transfer protein (PLTP) is involved in lipid metabolism and inflammatory responses, but its clinical significance in sepsis remains incompletely understood. We investigated the association between plasma PLTP activity and clinical characteristics, acute kidney injury (AKI), and mortality in patients with sepsis. Methods This observational study included 106 patients with sepsis admitted to the intensive care unit, 37 non-sepsis ICU patients and 38 healthy volunteers. Plasma PLTP activity was measured serially at predefined time points during hospitalization. Associations between PLTP activity and clinical variables were evaluated using correlation and multivariable analyses. Longitudinal changes in PLTP activity were assessed using a linear mixed-effects model with patient-specific random intercepts. Receiver operating characteristic (ROC) curve analysis was used to evaluate the association of Day 1 PLTP activity with 28-day mortality. Results PLTP activity was highest in sepsis (214.00 ± 73.69 pmol/L/h), intermediate in non-sepsis (140.70 ± 37.41 pmol/L/h), and lowest in healthy controls (93.72 ± 14.03 pmol/L/h) ( p < 0.05). Non-survivors exhibited higher activity than survivors on days 1–5. PLTP activity was positively correlated with serum creatinine (day1–7) and was elevated in patients who developed AKI. Plasma PLTP activity on Day 1 independently predicted 28-day mortality with an AUC of 0.806 (95% CI: 0.711–0.901) and a cutoff of ≥235 pmol/L/h identified high-risk sepsis patients. Conclusions Elevated circulating phospholipid transporter protein (PLTP) activity is associated with 28-day mortality in patients with sepsis. These findings suggest that PLTP may have potential as a biomarker for clinical risk stratification. Trial Registration https://www.chictr.org.cn , Chinese Clinical Trial Registry ChiCTR2500098114.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-17
DOI
https://doi.org/10.3389/fmed.2026.1934469
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Elevated circulating phospholipid transporter protein activity is associated with 28-day mortality in patients with sepsis

Xingfang Wang, 若瑾 崔, Qinghe Meng, Hui Zhao et al.
1 links
Frontiers in Medicine
Sepsis Diagnosis and Treatment
article

Elevated circulating phospholipid transporter protein activity is associated with 28-day mortality in patients with sepsis

Xingfang Wang, 若瑾 崔, Qinghe Meng, Hui Zhao, Dawei Wang, Xin Zhang, Ke Zhang
article en

Abstract

Objectives Phospholipid transfer protein (PLTP) is involved in lipid metabolism and inflammatory responses, but its clinical significance in sepsis remains incompletely understood. We investigated the association between plasma PLTP activity and clinical characteristics, acute kidney injury (AKI), and mortality in patients with sepsis. Methods This observational study included 106 patients with sepsis admitted to the intensive care unit, 37 non-sepsis ICU patients and 38 healthy volunteers. Plasma PLTP activity was measured serially at predefined time points during hospitalization. Associations between PLTP activity and clinical variables were evaluated using correlation and multivariable analyses. Longitudinal changes in PLTP activity were assessed using a linear mixed-effects model with patient-specific random intercepts. Receiver operating characteristic (ROC) curve analysis was used to evaluate the association of Day 1 PLTP activity with 28-day mortality. Results PLTP activity was highest in sepsis (214.00 ± 73.69 pmol/L/h), intermediate in non-sepsis (140.70 ± 37.41 pmol/L/h), and lowest in healthy controls (93.72 ± 14.03 pmol/L/h) ( p < 0.05). Non-survivors exhibited higher activity than survivors on days 1–5. PLTP activity was positively correlated with serum creatinine (day1–7) and was elevated in patients who developed AKI. Plasma PLTP activity on Day 1 independently predicted 28-day mortality with an AUC of 0.806 (95% CI: 0.711–0.901) and a cutoff of ≥235 pmol/L/h identified high-risk sepsis patients. Conclusions Elevated circulating phospholipid transporter protein (PLTP) activity is associated with 28-day mortality in patients with sepsis. These findings suggest that PLTP may have potential as a biomarker for clinical risk stratification. Trial Registration https://www.chictr.org.cn , Chinese Clinical Trial Registry ChiCTR2500098114.

Frontiers in MedicineVol. 13
SUNY Upstate Medical University (US), Shandong Provincial Hospital (CN), Shandong First Medical University (CN)
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon